MKI67 and neoplasm: Expression of proliferative markers like Ki67 and cyclin B1 is higher in luminal B tumours than in luminal A. Tumours of this subgroup are associated with an unfavourable prognosis than in luminal A-type and may benefit from the chemotherapy [39].